Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.
Editorial Board
The journal features a first class Editorial Board and provides rigorous peer review and rapid online publication; see full list of Editorial Board members here.
Subscribe
For subscription information, click here.
ISSN
ISSN (p): 2352-3727
ISSN (e): 2352-3735
Audience
Bladder Cancer's targeted audience is comprised of basic science researchers and clinicians in the areas of bladder cancer and related disorders.
Abstracted/Indexed in
Cabell's Directory
DOAJ - Directory of Open Access Journals
Embase
Google Scholar
PubMed Central*
Scopus
Web of Science: Current Contents®/Life Sciences
Web of Science: Science Citation Index-Expanded (SciSearch®)
*Policy regarding the NIH Public Access Policy mandate (PubMed Central)
All articles published in Bladder Cancer are automatically transferred to PubMed Central by the publisher within 1 month from the final publication date.
The Publisher
IOS Press is an independent international scientific, technical, medical (STM) publishing house established in 1987 in Amsterdam. We produce around 90 journals and 70 books annually in a broad range of subject categories, primarily specializing in health and life sciences (including neurosciences, medical informatics, cancer research, and rehabilitation) and computer sciences (including artificial intelligence, data science, and semantic web). In addition, we offer specialized services that support scientific advancement.
